CEBPZ and leukemia: While not statistically significant, we found an enrichment for the presence of the miR-29 polymorphism in AML cases with CBF leukemia (n = 3/12: 25%) compared to controls (n = 43/402:11%) (Supplementary Table 1 and Figure 1C).